Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Return on Assets: 2014-2017

Historic Return on Assets for Soleno Therapeutics (SLNO) over the last 3 years, with Dec 2017 value amounting to -0.11%.

  • Soleno Therapeutics' Return on Assets rose 99.00% to -0.11% in Q4 2017 from the same period last year, while for Dec 2017 it was -0.11%, marking a year-over-year increase of 99.00%. This contributed to the annual value of -0.04% for FY2018, which is 12.00% up from last year.
  • Per Soleno Therapeutics' latest filing, its Return on Assets stood at -0.11% for Q4 2017, which was up 26.47% from -0.15% recorded in Q3 2017.
  • Soleno Therapeutics' 5-year Return on Assets high stood at -0.11% for Q4 2017, and its period low was -1.84% during Q4 2014.
  • Its 3-year average for Return on Assets is -0.99%, with a median of -1.20% in 2015.
  • As far as peak fluctuations go, Soleno Therapeutics' Return on Assets plummeted by 44bps in 2016, and later spiked by 151bps in 2017.
  • Quarterly analysis of 4 years shows Soleno Therapeutics' Return on Assets stood at -1.84% in 2014, then grew by 27bps to -1.57% in 2015, then skyrocketed by 47bps to -1.10% in 2016, then surged by 99bps to -0.11% in 2017.
  • Its Return on Assets stands at -0.11% for Q4 2017, versus -0.15% for Q3 2017 and -0.12% for Q2 2017.